1-Mozhgani SH, Malekpour SA, Norouzi M, Ramezani F, Rezaee SA, Poortahmasebi V, Sadeghi M, Alavian SM, Zarei-Ghobadi M, Ghaziasadi A, Karimzadeh H, Malekzadeh R, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Jahantigh HR, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Keyvani H, Kalantari E, Fakhari Z, Geravand B, Jazayeri SM

Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.

Arch Virol. 2018 Feb 13



2.Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015.

GBD 2015 SDG Collaborators.Lancet. 2016 Oct 8;388(10053):1813-1850



3.Katoonizadeh A, Sharafkhah M, Ostovaneh MR, Norouzi A, Khoshbakht N, Mohamadkhani A, Eslami L, Gharravi A, Shayanrad A, Khoshnia M, Esmaili S, George J, Poustchi H, Malekzadeh R

Immune responses to hepatitis B immunization 10-18 years after primary vaccination: a population-based cohort study.

J Viral Hepat. 2016 Oct;23(10):805-11



4.Mohammadi Z, Keshtkar A, Eghtesad S, Jeddian A, Pourfatholah AA, Maghsudlu M, Zadsar M, Mahmoudi Z, Shayanrad A, Poustchi H, Malekzadeh R

Epidemiological Profile of Hepatitis B Virus Infection in Iran in the Past 25 years; A Systematic Review and Meta-analysis of General Population Studies.

Middle East J Dig Dis. 2016 Jan;8(1):5-18



5..Katoonizadeh A, Ghoroghi S, Sharafkhah M, Khoshnia M, Mirzaei S, Shayanrad A, Poustchi H, Malekzadeh R

Chronic hepatitis B infection is not associated with increased risk of vascular mortality while having an association with metabolic syndrome

J Med Virol. 2016 Jul;88(7):1230-7



6.Ramezani F, Alavian SM, Sadeghi A, Khedive A, Ghalichi L, Norouzi M, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Keyvani H, Kalantari E, Saberfiroozi M, Rezaee R, Daram M, Mahabadi M, Goodarzi Z, Poortahmasebi V, Geravand B, Khamseh A, Mahmoodi M, Jazayeri SM

Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces.

 Iran J Microbiol. 2015 Aug;7(4):214-20



7.Poortahmasebi V, Malekzadeh R, Montazeri G, Fakhari E, Norouzi M, Khamseh A, Mahmoodi Karkhaneh M, Tavakoli A, Jazayeri SM

Lamivudine Resistance and Precore Variants in Iranian Patients With Chronic Hepatitis B: Correlation With Virological and Clinical Features.

Jundishapur J Microbiol. 2015 Sep 12;8(9):e20262



8.Besharat S, Poustchi H, Mohamadkhani A, Roshandel G, Freedman ND, Merat S, Malekzadeh R

Central Obesity and Advanced Liver Stiffness in Hepatitis B: Result from Golestan Hepatitis B Cohort Study.

Arch Iran Med. 2015 Sep;18(9):562-6


9.Besharat S, Poustchi H, Mohamadkhani A, Katoonizadeh A, Moradi A, Roshandel G, Freedman ND, Malekzadeh R

Association of Mutations in the Basal Core Promoter and Pre-core Regions of the Hepatitis B Viral Genome and Longitudinal Changes in HBV Level in HBeAg Negative Individuals: Results From a Cohort Study in Northern Iran.

Hepat Mon. 2015 Feb 21;15(2):e23875



10.Daram M, Montazeri G, Karimzadeh H, Malekzadeh R, Mahmoodi M, Goodarzi Z, Keyvani H, Mirmomen S, Alavian SM, Roggendorf M, Jazayeri SM

Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy.

  Iran J Basic Med Sci. 2014 Sep;17(9):638-45



11.Poustchi H, Katoonizadeh A, Ostovaneh MR, Moossavi S, Sharafkhah M, Esmaili S, Pourshams A, Mohamadkhani A, Besharat S, Merat S, Mohamadnejad M, George J, Malekzadeh R

Cohort profile: golestan hepatitis B cohort study- a prospective long term study in northern iran ​.

 Middle East J Dig Dis. 2014 Oct;6(4):186-94



12.Khedive A, Norouzi M, Ramezani F, Karimzadeh H, Alavian SM, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Somi MH, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Judaki MA, Ghamari S, Daram M, Mahabadi M, Fazeli Z, Goodarzi Z, Poortahmasebi V, Jazayeri SM.J

Hepatitis B virus surface protein mutations clustered mainly in CTL immune epitopes in chronic carriers: results of an Iranian nationwide study.

 Viral Hepat. 2013 Jul;20(7):494-501



13.Mahabadi M, Norouzi M, Alavian SM, Samimirad K, Azad TM, Saberfar E, Mahmoodi M, Ramezani F, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Hossein Somi M, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Ali Judaki M, Ghamari S, Daram M, Fazeli Z, Goodarzi Z, Khedive A, Moradi A, Jazayeri SM

Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients.

Hepat Mon. 2013 Jan 20;13(1):e6712



14.Modabbernia A, Ashrafi M, Malekzadeh R, Poustchi H

A review of psychosocial issues in patients with chronic hepatitis B.

Arch Iran Med. 2013 Feb;16(2):114-22



15. Norouzi M, Ghorashi S, Abedi F, Nejatizadeh A, Ataei B, Malekzadeh R, Alavian S, Judaki M, Ghamari S, Namazi A, Rahimnia R, Khedive A, Jazayeri S

Identification of Hepatitis B Virus Surface Antigen (HBsAg) Genotypes and Variations in Chronic Carriers from Isfahan Province, Iran.

Iran J Public Health. 2012;41(3):104-11



16.Lahsaee S, Ghazizade A, Yazdanpanah M, Enhesari A, Malekzadeh R

Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman.

 Gastroenterol Hepatol Bed Bench. 2012 Fall;5(4):183-9



17. Ashrafi M, Modabbernia A, Dalir M, Taslimi S, Karami M, Ostovaneh MR, Malekzadeh R, Poustchi H

Predictors of mental and physical health in non-cirrhotic patients with viral hepatitis: a case control study.

J Psychosom Res. 2012 Sep;73(3):218-24. doi: 10.1016/j.jpsychores.2012.06.006



18. Ghaziasadi A, Ziaee M, Norouzi M, Malekzadeh R, Alavian SM, Saberfar E, Judaki MA, Ghamari S, Khedive A, Namazi A, Rahimnia R, Jazayeri SM

The prevalence of hepatitis B virus surface antigen (HBsAg) variations and correlation with the clinical and serologic pictures in chronic carriers from Khorasan Province, North-East of Iran.

Acta Med Iran. 2012;50(4):265-72



19. Poorkaveh A, Modabbernia A, Ashrafi M, Taslimi S, Karami M, Dalir M, Estakhri A, Malekzadeh R, Pasha Sharifi H, Poustchi H

Validity, reliability and factor structure of Hepatitis B Quality of Life Questionnaire version 1.0: findings in a large sample of 320 patients.

Arch Iran Med. 2012 May;15(5):290-7



20. Modabbernia A, Ashrafi M, Keyvani H, Taslimi S, Poorkaveh A, Merat S, Poustchi H, Malekzadeh R

Brain-derived neurotrophic factor predicts physical health in untreated patients with hepatitis C.

Biol Psychiatry. 2011 Sep 1;70(5):e31-2



21.Montazeri G, Rahban M, Mohamadnejad M, Zamani F, Hooshyar A, Fazlolahi A, Abedian S, Ghoujeghi F, Estakhri A, Montazeri F, Razjoyan H, Mamarabadi M, Alimohamadi M, Tavangar SM, Malekzadeh R

Liver histology and HBV DNA levels in chronically HBV infected patients with persistently normal alanine aminotransferase.

Arch Iran Med. 2010 May;13(3):193-202



22.Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, Zaer-rezaii H, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R, Esmaili S

Seroprevalence of hepatitis C virus: the first population-based study from Iran.

Int J Infect Dis. 2010 Sep;14 Suppl 3:e113-6. doi: 10.1016/j.ijid.2009.11.032



23.Mohamadnejad M, Tavangar SM, Sotoudeh M, Kosari F, Khosravi M, Geramizadeh B, Montazeri G, Estakhri A, Mirnasseri MM, Fazlollahi A, Zamani F, Malekzadeh R

Histopathological Study of Chronic Hepatitis B: A Comparative Study of Ishak and METAVIR Scoring Systems.

Int J Organ Transplant Med. 2010;1(4):171-6



24-Mohamadkhani A, Sotoudeh M, Bowden S, Poustchi H, Jazii FR, Sayehmiri K, Malekzadeh R

Downregulation of HLA class II molecules by G1896A pre-core mutation in chronic hepatitis B virus infection.

Viral Immunol. 2009 Oct;22(5):295-300. 25



25-Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, Radmard AR, Zaer-Rezaii H, Zeid-Abadi-Nejhad M, Hosseini MR, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R

The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study.

Arch Iran Med. 2009 May;12(3):225-31



27.Jamali R, Pourshams A, Amini S, Deyhim MR, Rezvan H, Malekzadeh R

The upper normal limit of serum alanine aminotransferase in Golestan Province, northeast Iran.

Arch Iran Med. 2008



28. Poustchi H, Mohamadkhani A, Bowden S, Montazeri G, Ayres A, Revill P, Farrell GC, Locarnini S, George J, Malekzadeh R

Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease.

J Viral Hepat. 2008 Oct;15(10):753-60



29-Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, Forouzanfar MH, Abedian S, Tavangar SM, Mohamadkhani A, Ghoujeghi F, Estakhri A, Nouri N, Farzadi Z, Najjari A, Malekzadeh R

Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.

Am J Gastroenterol. 2006 Nov;101(11):2537-45



30. Kabir A, Alavian SM, Ahanchi N, Malekzadeh R

Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone.

Hepatol Res. 2006 Dec;36(4):265-71



31. Montazeri G, Estakhri A, Mohamadnejad M, Nouri N, Montazeri F, Mohammadkani

Serum hyaluronate as a non-invasive marker of hepatic fibrosis and inflammation in HBeAg-negative chronic hepatitis B.

2005 Oct 12;5:32



32.Mohamadnejad M, Malekzadeh R

Hepatitis B.

N Engl J Med. 2004 Jun 24;350(26):2719-20 



33.Malekzadeh R, Mohamadnejad M, Rakhshani N, Nasseri-Moghaddam S, Merat S, Tavangar SM, Sohrabpour AA

Reversibility of cirrhosis in chronic hepatitis B.

Clin Gastroenterol Hepatol. 2004 Apr;2(4):344-7

اشتراک گذاری در شبکه های اجتماعی